Zag Group

Zymeworks is a Vancouver-based company dedicated to developing innovative medicines for patients grappling with challenging medical conditions. Their groundbreaking technologies are engineered to create tailored biotherapeutics, addressing high unmet medical needs. At Zymeworks, a team of renowned researchers leads a fully integrated R&D process, spanning from target selection to pivotal studies. Their focus lies in discovering, developing, and commercializing novel agents globally, in collaboration with partners and collaborators. The company's scientific efforts concentrate on transforming areas with significant medical gaps, particularly in treating complex cancers and other severe diseases. Zymeworks boasts a robust pipeline of multifunctional therapeutics supported by cutting-edge platforms for antibody-drug conjugates and multispecific antibody therapeutics. Generated from the website content